TAK-915,99.74%

产品编号:Bellancom-103493| CAS NO:1476727-50-0| 分子式:C19H18F4N4O5| 分子量:458.36

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-103493
9200.00 杭州 北京(现货)
Bellancom-103493
14800.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

TAK-915

产品介绍 TAK-915 是一种有效的,选择性的,可透过血脑屏障和口服活性的 PDE2A抑制剂,IC50 为 0.61 nM。TAK-915 对 PDE2A的选择性是 PDE1A 的 4100 倍以上。TAK-915 可用于神经精神疾病和神经退行性疾病的研究。
生物活性

TAK-915 is a potent, selective, brain-penetrant and orally active phosphodiesterase 2A (PDE2A) inhibitor with an IC50 of 0.61 nM. TAK-915 is >4100-fold more selectivity for PDE2A than PDE1A. TAK-915 has the potential for neuropsychiatric and neurodegenerative disorders treatment.

体外研究
体内研究

TAK-915 (3 mg/kg; oral administration; daily; for 4 days; male F344 rats) treatment significantly reduces escape latency in aged rats in the Morris water maze task.
TAK-915 (1, 3, and 10 mg/kg, p.o.) dose-dependently attenuates the non-selective muscarinic antagonist scopolamine-induced memory deficits in rats.
Oral dosing of TAK-915 (compound 36) (3 or 10 mg/kg) in mice produces a dose-dependent increase in 3',5'-cyclic guanosine monophosphate (cGMP) levels, with significant cGMP increases observed at a dose of 10 mg/kg.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male F344 rats (10-week-old and 26-month-old) bearing morris water maze task
Dosage: 3 mg/kg
Administration: Oral administration; daily; for 4 days
Result: Significantly reduced escape latency in aged rats in the Morris water maze task.
体内研究

TAK-915 (3 mg/kg; oral administration; daily; for 4 days; male F344 rats) treatment significantly reduces escape latency in aged rats in the Morris water maze task.
TAK-915 (1, 3, and 10 mg/kg, p.o.) dose-dependently attenuates the non-selective muscarinic antagonist scopolamine-induced memory deficits in rats.
Oral dosing of TAK-915 (compound 36) (3 or 10 mg/kg) in mice produces a dose-dependent increase in 3',5'-cyclic guanosine monophosphate (cGMP) levels, with significant cGMP increases observed at a dose of 10 mg/kg.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male F344 rats (10-week-old and 26-month-old) bearing morris water maze task
Dosage: 3 mg/kg
Administration: Oral administration; daily; for 4 days
Result: Significantly reduced escape latency in aged rats in the Morris water maze task.
性状Solid
溶解性数据
In Vitro: 

DMSO : 7.5 mg/mL (16.36 mM; ultrasonic and warming and heat to 60°C)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.1817 mL 10.9085 mL 21.8169 mL
5 mM 0.4363 mL 2.1817 mL 4.3634 mL
10 mM 0.2182 mL 1.0908 mL 2.1817 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服